Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy Background In 2021, there will be an estimated 76,080 new cases of kidney cancer in the US (48,780 in men and 27,300 in women) and about 13,780 patients (4,990 women, 8,790 men) will die from this disease. The most common form of kidney
Oncology
Second Primary Malignancies of Eye and Ocular Adnexa
Thermography in clinical ophthalmic oncology
THERMOGRAPHY AS A SCREENING TOOL IN CLINICAL OPHTHALMIC ONCOLOGY STUDY BACKGROUND Although intraocular tumors are rare, with an incidence of 5 per million adults, the diagnosis has been biased towards the physical examination, Color Doppler Imaging (CDI), Optical Coherence Tomography (OCT), Indocyanine Green Angiography (ICGA), or Fluorescein Angiography (FA). Literature reviews suggest
Involvement of Ocular Surface in Graft‐Versus‐Host Disease: A Review
Involvement of Ocular Surface in Graft-Versus-Host Disease: A Review Hematopoietic stem cell transplantation (HSCT) is a promising curative therapy for hematologic malignancies and other disorders of blood and bone marrow. Historically, HSCT was referred to as bone marrow transplantation (BMT) because bone marrow was the sole source of transplanted hematopoietic stem
Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions
Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions Most orbital space-occupying lesions come from tissues in the orbital space or metastasize from other system tumors. The bulk of clinical manifestations of these lesions such as diplopia, protrusion, and loss of vision are often nonspecific, so imaging technology is crucial
Risk Factors for Ocular Metastases in Invasive Ductal Carcinoma
Myelofibrosis – Biology, Management, and Case Report of Ocular Manifestation
MF-BIOLOGY, MANAGEMENT, AND CASE REPORT OF OCULAR MANIFESTATION Myelofibrosis is an uncommon myeloproliferative neoplasm, a type of blood cancer where excess red blood cells, white blood cells, or platelets are produced in the bone marrow. The rarity of this abnormality has many medical professionals struggling to understand its genetic underpinnings. This
Malignancy in Myelofibrosis Patients Receiving Ruxolitinib Therapy
A Restrospective Study of Secondary Malignancies in Myelofibrosis Patients Receiving Ruxolitinib Therapy Myelofibrosis (MF) is a chronic, rare, and often fatal type of blood cancer characterized by a progressive replacement of bone marrow with fibrous scar tissue. This type of myeloproliferative neoplasm (MPN) leads to progressive spleen enlargement, systemic symptoms such
Study on the Ocular involvement in metastatic and systemic malignancies
Ocular Involvement of Systemic Malignancies Systemic malignancies affecting the eye often involve the choroid or the orbital area of the eye, leading to different ocular manifestations. Ocular malignancies are relatively rare compared to malignancies of other parts of the human body. The American Cancer Society estimates there will be about 3,300 new eye cancer
Genetic Mutations for Predicting Pancreatic Ductal Adenocarcinoma Susceptibility
Genetic Mutations for Predicting Pancreatic Ductal Adenocarcinoma Susceptibility Pancreatic ductal adenocarcinoma (PDAC) is the deadliest malignancy representing about 90% of all pancreatic cancers. PDAC progresses asymptomatically until death and is refractory to most treatment methods. Surgery is the most effective treatment. Nevertheless, it is well known that only 15-20% of PDAC
